PRIMARY STUDY

Synthetic cannabinoids and ST elevation myocardial infarction

Key Findings:  A patient presented to the emergency room with severe chest pain and was diagnosed with an ST elevation myocardial infarction (STEMI). He was otherwise healthy, except for a new diagnosis of COVID-19 and synthetic cannabis use. The latter is concerning as a contributing factor to this case of unexpected coronary artery thrombosis and should prompt rapid angiography and stent placement.